Weekly Top Stories: Doug Ford Seeks Accelerated Medication Approval Process at Premier’s Meeting
This week’s spotlight falls on the Council of the Federation meeting in Halifax, Nova Scotia, where Ontario Premier Doug Ford has taken a leading role in advocating for an accelerated medication approval process. Ford seeks to address concerns that it takes nearly two years for new drugs to reach patients, compared to much shorter times in other countries. A spokesperson for the Ontario premier highlighted the need to maintain Canada’s position in healthcare innovation by ensuring timely access to new medicines. This push for faster approvals aligns with broader discussions on healthcare innovation and accessibility taking place at the premiers’ meeting. While the premiers convened, healthcare professionals, unions, and advocates gathered at the Peace and Friendship Park in Halifax to voice their concerns about the ongoing healthcare crisis. They urged government leaders to address growing concerns and develop solutions amidst ongoing challenges in the healthcare system. During the rally, Steven Staples, director of policy and advocacy at the Canadian Health Coalition, emphasized the findings of a survey regarding widespread concern among Canadians about the state of the healthcare system. Staples expressed fears that privatization could exacerbate existing issues. For its part, the Canadian Federation of Nurses Unions (CFNU) presented proposals to address critical staffing challenges from primary care to long-term care. CFNU has urged government collaboration on evidence-based solutions to bolster the recovery of healthcare systems. Key recommendations included implementing nurse-patient ratios to alleviate excessive workloads and enhance patient care, enforcing mandatory standards for long-term care to ensure safety and quality for seniors, and guaranteeing universal access to primary care across communities. The president of the Newfoundland and Labrador Medical Association, Dr. Steve Major, said the lack of family doctors is the province’s most pressing healthcare issue, which Premier Andrew Furey wants to discuss during the premiers’ meeting. Dr. Major highlighted the urgent need for a comprehensive, long-term strategy to address the province’s critical shortage of family physicians. Ina significant move to bolster Canada’s healthcare workforce, Parliamentary Secretary to the Minister of Health Yasir Naqvi, along with Minister of International Development Ahmed Hussen, visited the Medical Council of Canada on July 11 and announced over $47 million in federal funding, of which around $22.5 million will be allocated to Health Workforce Canada. This funding is intended to enhance the accessibility of health workforce data and facilitate the dissemination of practical solutions and innovative practices. At the provincial level, Ontario is making strides to improve emergency care and primary care access. Minister of Colleges and Universities Jill Dunlop emphasized the importance of the province’s $10 million investment in emergency department care training to address hospital staffing shortages. Deputy Premier and Minister of Health Sylvia Jones also praised the initiative as a crucial advancement, highlighting its impact on upskilling over 1,000 nurses, with 400 already recruited from rural and remote hospitals since the program’s inception last year. Furthermore, Ontario is investing over $14 million to connect up to 49,000 Toronto residents to primary care teams. advancing its goal of providing primary care access to all residents as part of a broader $110 million effort to expand primary care across the province. Health Minister Jones emphasized that the Ontario government is committed to providing faster and easier access to treatments, with Premier Doug Ford working to ensure all Canadians receive timely, life-saving care on par with global standards. However, challenges remain. The Ontario Medical Association responded to the Minister’s statement, urging the government to address the 2.5 million Ontarians without a family doctor, despite efforts to improve access to life-saving treatments. These developments collectively paint a picture of a healthcare system in flux, with governments at all levels working to address longstanding challenges and adapt to evolving healthcare needs. For an in-depth analysis of these developments and their potential impacts, contact Delphic Research today.
Delphic Research Welcomes Accomplished Public Servant Colin Andersen as Strategic Advisor
Delphic Research Welcomes Accomplished Public Servant Colin Andersen as Strategic Advisor Delphic Research is pleased to welcome Colin Andersen as Strategic Advisor. Colin is a highly accomplished senior executive with over 20 years of experience across both the public and private sectors. Colin will focus on expanding Delphic Research’s relationships within Ontario’s health sector, as well as lead the investigation into new practice areas to be developed by Delphic Research. Throughout his career, Colin has excelled in navigating complex, high-profile portfolios and government decision-making processes. His unique ability to guide diverse stakeholders through change and achieve alignment has earned him a reputation as a principled leader and trusted advisor. His expertise spans health system transformation, energy policy, government relations, and digital wellness, making him a valuable asset to Delphic Research. Colin has a deep understanding of the challenges faced by government affairs professionals, having served as a former senior public servant in the Ontario government, across multiple portfolios, including as associate deputy minister for Ontario’s Ministry of Health and Long-Term Care. Colin understands how the machinery of government works unlike few others. As deputy minister for the ministries of Finance and Revenue, he oversaw the development of five Ontario budgets and, as Secretary of Treasury Board, he would play an even more pivotal role in how the execution of those budgets would be managed. His time in Cabinet Office, as deputy minister for policy, also provided him with a unique perch across the whole of the Ontario government, its priorities, and operations. Colin’s depth of expertise also extends to the energy sector, where he spent six years at CEO of the Ontario Power Authority, as well as serving as chair of the Ontario Electricity Financial Corporation and nearly seven years leading the Energy Council of Canada as it’s board chair. Most recently, Colin was Executive VP for digital health company, Mind Beacon, where he also led its public sector practice up until the company’s recent acquisition.
Weekly Top Stories: Dr. Clifford Lo as Acting Deputy CEO of pCPA; and the Severe Workforce Shortage
This week brings a mix of urgent challenges and a promising leadership appointment, highlighting the critical juncture at which Canada’s healthcare system stands. From a staggering rise in Ontario’s family doctor shortage to calls for healthcare reform and significant investments aimed at easing the burden on healthcare professionals. Ontario is grappling with a severe family doctor shortage, with new data revealing that 2.5 million residents are now without a family doctor, up from 1.8 million in 2020. The Ontario College of Family Physicians is calling for urgent support to address the shortage. Dr. Archna Gupta has emphasized the increased reliance on hospital emergency departments and less frequent cancer screenings due to this shortage, predicting that the number of Ontarians without family doctors could surpass 4 million by 2026. In connection with this, 670,000 patients are forced to retain their doctors despite living over 50 kilometres away. According to the Ministry of Long-Term Care, Toronto has lost 650 nursing home beds in the last three years. Dr. Samir Sinha discussed the impact of these closures on the Long-Term Care community. In British Columbia, the provincial government announced that more family doctors would be trained at the new medical school at SFU, the first new medical school in western Canada in 55 years, as part of efforts to improve healthcare reliability. Meanwhile, the pan-Canadian Pharmaceutical Alliance (pCPA) has appointed Dr. Clifford Lo as its new acting deputy CEO. Dr. Lo previously served as the director of the Formulary Management Branch of the B.C. Ministry of Health Pharmaceutical Services Division and as the Provincial Pharmacy Lead of the British Columbia Provincial Renal Agency. As a pharmacist with a master’s degree in health administration from the University of British Columbia and an executive master’s degree in health economics, policy, and management from the London School of Economics and Political Science, Dr. Lo brings extensive expertise to this role. In anticipation of the Council of the Federation meeting, Canada’s nurses unions are urging provincial leaders to commit to a transformative overhaul of public healthcare, emphasizing the need for universal access to care and improved health workforce conditions. President Linda Silas of the Canadian Federation of Nurses Unions stresses the importance of addressing critical health issues exacerbated by inadequate access to primary and long-term care, calling for collaborative action to strengthen Canada’s public healthcare system. Dr. Joel Antel, President of the Canadian Dental Association, highlighted misconceptions about Canada’s new $13 billion Canadian Dental Care Plan (CDCP). He outlined the challenges in public understanding and dentist participation, highlighting the need for clearer communication for effective implementation and patient care. As a commitment towards improving healthcare, Health Canada and the Canadian Institutes of Health Research have committed over $47 million to healthcare workforce research and planning, which aims to ease the workload and responsibilities of healthcare professionals. The initiative aims to enhance data accessibility, streamline physician licensing, and explore new solutions to strengthen the healthcare workforce. In another important development, Health Canada is set to announce a new implementation process for the CDCP to improve access to oral health care for eligible Canadians. Stay informed with our comprehensive coverage andanalysis, delivered to you weekly through our full-spectrum monitoring. Book afree consultation today!
Weekly Top Stories: Key Appointments and Important Shifts in Healthcare
In this edition, we will update you on the latest appointments and critical healthcare shifts. All of these are delivered to you weekly through our full-spectrum monitoring. On July 3, Prime Minister Justin Trudeau made history by appointing Lieutenant-General Jennie Carignan as Chief of the Defence Staff, making her the first woman to lead the Canadian Armed Forces, succeeding General Wayne Eyre. Carignan will oversee CAF operations worldwide, focusing on national defence, humanitarian aid, and NATO support. This decision is set to inspire future generations of women in the armed forces. In addition to this, on June 28, Trudeau appointed Victor Boudreau as an independent senator for New Brunswick. With an extensive 30-year career in provincial politics and dedicated community service, including roles in finance, economic development, and health, Boudreau’s appointment welcomes the commitment to bringing seasoned and knowledgeable leaders into legislation. Continuing her pivotal role in shaping Canada’s scientific landscape, Dr. Mona Nemer was reappointed as Canada’s Chief Science Advisor for another three-year term, effective September 25, 2024. Dr. Nemer, a distinguished medical researcher, has been the advisor since 2017. Her reappointment will help ensure continued focus on scientific integrity and evidence-based policymaking. In a move towards greater inclusivity, Employment and Social Development Canada announced that Canadians aged 55 and over who identify as 2SLGBTQI+ are invited to participate in online consultations until July 17, 2024, aimed at supporting them to age comfortably at home and in their communities. Minister Seamus O’Regan Jr. emphasized the importance of ensuring dignity and choice for 2SLGBTQI+ seniors, highlighting their historical advocacy for rights within the Federal 2SLGBTQI+ Action Plan.The initiative underscores a commitment to equitable societal progress where every voice, including those of 2SLGBTQI+ seniors, contributes to a fairer, more supportive environment. Amidst these notable appointments and initiatives, Ontario’s healthcare crisis has reached a critical juncture. Nurses in Ontario have raised alarm over the state of healthcare in Ontario, highlighting severe staffing shortages and the impact of underfunding on patient care. They criticized the Ontario government’s policies, including moves towards privatization, arguing they heighten the crisis by neglecting public health needs and driving experienced nurses away from the system. In an opinion column, experts criticized a recent deal allowing private long-term care development on public land in Ottawa, arguing it prioritizes profit over patient care and transparency. They raised concerns about the implications for residents’ safety and the unsafe conditions faced by healthcare workers, urging reconsideration of the agreement amid ongoing health and housing crises in the city. As we move forward, these developments reflect the complex balance Canada must strike in its pursuit of excellence and equity across all sectors. Experience our full-spectrum monitoring, contact us today!
Weekly Top Stories: Canada Takes Bold Steps in Dental Care and Medical Research
This week marks a turning point in Canada’s healthcare landscape, with expansions in dental coverage and significant investments in research. The spotlight this week falls on the expansion of the Canadian Dental Care Plan. Health Minister Mark Holland, Public Services Minister Jean-Yves Duclos, Families Minister Jenna Sudds, Diversity Minister Kamal Khera, and Citizens’ Services Minister Terry Beech announced that Canadian children under 18 and adults with a valid Disability Tax Credit certificate can now apply for the plan. The expansion aims to provide affordable dental care to approximately 1.2 million more Canadians, building on the plan’s success, which has benefitted over 2 million seniors since its launch. The initiative allows access to services like cleaning, fillings, and dentures, with applications open immediately, promising improved oral health for 938,000 children and 183,000 adults. In a related development, the Canada Revenue Agency has issued a reminder about the July 30 deadline for the second round of applications for the Canada Dental Benefit. Eligible families can receive up to $650 per child per year for two years, provided that they received dental care from July 1, 2023, to June 30,2024. While these dental care initiatives represent positive steps, a recent report by the Fraser Institute underscores substantial economic consequences due to prolonged healthcare wait times. In 2023 alone, delays in non-emergency treatments cost the nation $3.5 billion in lost wages and productivity, averaging $2,871 per person waiting for procedures. These figures prompt calls for reforms that include greater integration of private sector solutions to alleviate strain on patients and improve access to timely care. On the research front, the Heart + AVC, in collaboration with the Brain Canada Foundation and the Canadian Institutes of Health Research, has launched significant initiatives to advance research dedicated to improving lifelong care and outcomes for patients. Funding has been awarded to three research teams led by Luc Mertens, Thalia Field, and Andrew Mackie. The teams will focus on early detection, brain health, and optimizing care transitions, highlighting a concerted move towards addressing physical and mental health concerns associated with congenital heart disease across different stages of life. Stay informed about the latest developments in your industry. Contact us for more in-depth coverage!
Weekly Top Stories: Canada Leads Global Debut of Awiqli®, Novo Nordisk’s once-weekly insulin icodec injection
This edition highlights progress in diabetes innovation, here led by Novo Nordisk, and which speaks to ongoing efforts to revolutionize treatments and enhance patient outcomes not just in Canada, but around the world. The highlight of the week is undoubtedly Novo Nordisk’s introduction of Awiqli® (insulin icodec injection) in Canada, making it the world’s first once-weekly basal insulin available for diabetes treatment starting June 30, following its approval by Health Canada on March 12, 2024. This marks a significant addition to diabetes care led by Novo Nordisk with the world’s first once-weekly basal insulin. According to the company, this new insulin option aimed to improve glycemic control and will alleviate the burden of daily injections for the over 4.1 million Canadians with diagnosed diabetes, addressing a significant need as a majority expressed interest in less frequent administration regimes. Kate Hanna, speaking on behalf of Novo Nordisk, highlighted the positive reception from private drug plans, stating, “We are seeing positive early signals that private drug plans see the value Awiqli provides patients living with both Type 1 and Type 2 diabetes.” In connection, Dr. Richard Dumas, the director of the Laval Clinical Research Centre, discussed the drug’s convenience and suitability for basal insulin users initiating treatment in a TV Anouvelles report. In the article, Sylvie Lauzon, President of Diabetes Quebec, was also featured and she stated that research and innovation were crucial in assisting with diabetes management. Additionally, the Canadian Press, Weekly Voice, and Zoomer Radio featured two endocrinologists who shared their thoughts on the matter. Dr. Harpreet Bajaj, head of Diabetes Canada’s clinical practice guidelines steering committee, highlighted the significance of Awiqli, particularly for Canadians with type 2 diabetes, noting its potential to alleviate the daily injection burden. Dr. Alexander Abitbol, assistant medical director at LMC Healthcare, emphasized the new insulin’s benefit in managing blood sugar levels more consistently over a week, potentially reducing long-term complications associated with untreated diabetes. However, both of them also brought up concerns over the drug’s higher cost compared to daily insulin shots. According to them, this factor could affect accessibility, despite its anticipated positive impact on diabetes management. Canadians with diabetes talked about the convenience of using Awiqli® as it lowers their frequency of taking insulin shots in a City News Everywhere interview. They also called for insurance coverage for this new diabetes medication. Beyond diabetes care, this week also witnessed significant investments in aging and brain health solutions as the Centre for Aging + Brain Health Innovation (CABHI) announced a $9.5 million investment through its Mentorship, Capital, and Continuation Program to support innovation in the aging and brain health sector, aligning with Canada’s National Dementia Strategy. Companies like QurCan Therapeutics and PragmaClin are among the beneficiaries, with investments targeting cognitive and age-related disorders and digital health solutions for Parkinson’s disease, respectively. Have access to the latest news in your industry, contact us today!
Weekly Top Stories: Statistics Canada Study Reveals Slowing Growth in the Pharmaceutical Industry
This week’s edition includes insights from a recent Statistics Canada report, revealing a concern about the growth of Canada’s innovative pharmaceutical industry, and an analysis from the Winnipeg Free Press, highlighting the high stakes surrounding the Pharmacare bill currently under Senate review. The innovative pharmaceutical industry’s research and development (R&D), operating profits, and employment rate have recorded slowing growth, according to a new Statistics Canada report. The pharmaceutical industry reported that its added value to the gross domestic product only increased from $15.9 billion to $16 billion, tallying a $2.2 billion loss and a 4.9% decline in employment in 2021. Despite the decline in key measures, Innovative Medicines Canada (IMC) highlighted the industry’s impact on the Canadian economy. According to the IMC, the innovative pharmaceutical industry has invested nearly $3 billion in R&D, generating 102,000 jobs. Shifting to legislative proceedings surrounding Bill C-64, the Pharmacare Act, witnesses from the heads of the Canadian Association for Pharmacy Distribution Management (CAPDM), the Canadian Federation of Nurses Unions, and JDRF Canada were present during the Standing Committee on Health (HESA) May 24 meeting. Angelique Berg, President and CEO of CAPDM, supported the bill’s goal of balancing medication affordability and access but cautioned against potential negative impacts on the supply chain and drug pricing. Linda Silas, President of the Canadian Federation of Nurses Unions, urged legislators to pass the bill and advocated for a universal, single-payer pharmacare program. Although, Jessica Diniz, President and CEO of JDRF Canada, emphasized the need for equitable and affordable access to medications and devices for managing type 1 diabetes, she supported the bill’s goals while recommending that it include provisions. However, Dr. Durhane Wong-Rieger, President and CEO of the Canadian Organization for Rare Disorders, expressed concerns about the bill’s implications for the rare disease community, saying that only 5% of rare diseases have effective therapies, with many patients facing delays and access barriers. The Winnipeg Free Press provides a critical analysis of the ongoing efforts surrounding the Pharmacare bill, stating that it “could be a crowning achievement for the federal Liberal-NDP alliance,” if they get it right. The op-ed outlined major concerns on the ambitious bill, including high costs and operational problems. If passed, the first phase of Pharmacare will cost $1.5 billion over five years, but a full coverage program will amount to $40 billion annually, translating to higher taxes for Canadians. Furthermore, the federal government’s operational problems on the dental care program does not bode well for Pharmacare. In other news, the Strongest Families Institute, a charity offering phone-based mental health programs for children and families, has expanded its services in Newfoundland and Labrador. Health Minister Tom Osborne re-announced a $500,000 investment from Budget 2024, allotting resources for anxiety, depression, and behaviour issues. The provincial government of Newfoundland and Labrador also invested over $450,000 from its Research and Innovation Fund to support Memorial University’s acquisition of the Orbitrap Mass Spectrometry system. The state-of-the-art equipment will enable research in chronic diseases such as osteoarthritis, nonalcoholic fatty liver disease, Alzheimer’s, and multiple sclerosis. Try our full-spectrum monitoring today!
Delphic Research Welcomes Brad Sinclair as Strategic Advisor for Ontario’s Health Sector
Delphic Research is thrilled to welcome Brad Sinclair, a distinguished health and public policy leader with over 35 years of experience, as our new Strategic Advisor for Ontario’s health sector, with a particular focus on regulated health professions. In his new role, Brad will provide strategic counsel to Jason Grier, Delphic Research Founder and CEO, on expanding the reach of the company’s subscription-based information platform to a broader group of health and life science clients. In parallel, Brad will lead efforts to develop an education and talent development focus practice vertical. Brad’s extensive career includes key roles such as Chief of Staff for Health & Long-Term Care Minister George Smitherman, Founding Executive Director of HealthForceOntario Marketing & Recruitment Agency, Executive Director of IMG-Ontario, and Director of the Ontario Council of Teaching Hospitals. He has also served as the Director of Health Sciences for the Council of Ontario Universities and Secretary to the Council for the Council of Ontario Universities. Throughout his career, Brad has navigated the complex landscape of health human resources (HHR), working with government, academic health sciences, health professional regulatory colleges, and associations. His expertise in discussion, negotiation, compromise, and data-driven policy has positioned him at the forefront of the sector. We are excited to have Brad Sinclair join our growing team and look forward to his contributions in driving strategic growth and innovation at Delphic Research.
Weekly Top Stories: Mixed Reactions as Pharmacare Act Moves Toward Universal Drug Coverage
This week’s edition included notable advancements in healthcare reform, which featured both positive developments and heated discussions. Also a number of significant shifts in the political landscape, including major cabinet changes in Ontario. The recent passage of Bill C-64, the Pharmacare Act, through the House of Commons brings Canada a step closer to a universal, single-payer national pharmacare program. The bill, sponsored by Health Minister Mark Holland, received praise from healthcare professionals, labour activists, and patient advocates, who view it as a major advancement in healthcare. However, the bill has faced criticism from insurance and corporate lobbyists. The Canadian Chamber of Commerce, in a statement from Senior Vice President Kathy Megyery, expressed concerns about its potential impact on the private insurance plans of 27 million Canadians. Further, Stephen Frank, President and CEO of the Canadian Life and Health Insurance Association, emphasized the need to amend the bill to ensure it aligns with Minister Holland’s assurances that existing workplace benefits will not be affected, thereby preserving choice and preventing potential gaps in drug coverage. However, the Registered Nurses’ Association of Ontario and the Canadian Labour Congress urged the Senate to swiftly pass Bill C-64 and prioritize Canadians’ health over pharmaceutical and insurance industry interests. Both groups emphasized the bill’s potential to enhance healthcare, alleviate financial burdens for families, and ensure control over sexual and reproductive health. In an open letter addressed to all Senators, Innovative Medicines Canada (IMC) emphasized the importance of careful consideration regarding the Pharmacare bill. IMC is urging for measures that elevate Canadians’ access to innovative medicines. IMC’s statement reflects its commitment to ensuring that any proposed Pharmacare program maintains high healthcare standards. While these developments are welcomed, it’s crucial to remain vigilant, especially in light of the data revealed by Manulife Canada’s Employee Health Report. The report revealed two alarming trends in the Canadian workforce, including increased use of obesity medications and a notable uptick in prescriptions for substance abuse. Manulife Group Benefits aggregated claims data and found that the use of anti-obesity drugs has increased 42.3% year-over-year, amounting to 91.9% since 2021. Additionally, Canadians’ use of substance abuse disorder drugs has increased by 17.2% year-over-year. These findings underscore the pressing need for comprehensive healthcare solutions to address these growing health challenges among Canadians. The expansion of the Canadian Dental Care Plan (CDCP) represents another significant step in improving overall healthcare access. Minister Holland recently expressed frustration with the dental community’s reluctance to fully support the CDCP, despite extensive efforts to address their concerns. As of now, the program boasts the participation of over 10,500 oral health providers, with more than 2 million seniors already approved for coverage. The initiative, aimed at providing essential dental care to Canadians lacking private insurance, is set to undergo a major expansion on June 27 to include children under 18 and people with disabilities; a move that will make 1.2 million additional Canadians eligible. This expansion is part of a gradual rollout that began on May 1 for seniors, with plans to extend to all Canadians aged 18 to 64 by January 2025. Ultimately, the CDCP aims to cover a quarter of Canadian residents without private dental plans, reflecting a $13 billion investment over five years. In other news, on the last day of the legislative session, Ontario Premier Doug Ford announced a major cabinet shuffle following the resignation of Steve Clark, Minister of Municipal Affairs and Housing. Stephen Lecce, Ontario’s education minister since 2019, was appointed as the new Minister of Energy and Electrification, switching roles with Todd Smith. According to Ontario’s news release, other changes include Stan Cho as Minister of Tourism, Culture and Gaming, Lisa Thompson as Minister of Rural Affairs, Rob Flack as Minister of Farming, Agriculture and Agribusiness, Mike Harris as Minister of Red Tape Reduction, and Natalia Kusendova-Bashta as Minister of Long-Term Care. Get our full-spectrum monitoring today; book a free consultation with us to learn how!
Weekly Top Stories: Ontario Chamber of Commerce Calls for Urgent Action to Tackle Substance Abuse Crisis
This week has been marked by developments across Ontario as healthcare providers and the government grapple with pressing issues ranging from substance abuse to a critical shortage of family doctors and the expansion of dental services. As the province contends with more than 3,000 annual drug poisoning deaths for the fifth consecutive year, translating to over eight deaths per day, the Ontario Chamber of Commerce (OCC) demanded urgent action to address the escalating substance abuse and overdose crisis in Ontario. With frontline businesses facing increasing security costs and declining customer traffic, the report, “Beyond Emergency Declarations: Charting Ontario’s Course Through the Substance Use and Overdose Crisis,” seeks to bridge knowledge gaps, advocate for evidence-based solutions, and emphasize the importance of prioritizing public health principles to prevent mortality and enhance recovery outcomes. The crisis, highlighted by the rising toxicity of the drug supply, declining mental health, and stigma within healthcare settings, disproportionately affects northern, remote, and rural communities with limited access to support services. “Without urgent action, our province faces devastating, long-term socio-economic harm,” Daniel Tisch, President and CEO of the OCC, warned. Meanwhile, in response to Renfrew County’s alarming spike in opioid-related deaths, local law enforcement, spearheaded by Inspector Stefan Neufeld, Detachment Commander of the Upper Ottawa Valley (UOV) Ontario Provincial Police (OPP), enforced proactive measures in hopes of addressing the opioid crisis in rural Eastern Ontario and slowing down the drug trade in the Ottawa Valley. Patrol units are now equipped with naloxone kits that reverse overdose effects from opioids like heroin, morphine, fentanyl, carfentanil, and codeine. An outreach patrol was also launched, partnering mental health professionals with patrols”to allow a trained professional to deal with the underlying psychological issues.” Neufeld also enhanced the Community Street Crime Unit (CSCU) to tackle the influx of illegal drugs and associated crimes more effectively. The substance abuse crisis is not the only healthcare challenge facing Ontario. The Ontario Medical Association (OMA) is urging the development of a comprehensive healthcare strategy to address the critical shortage of family doctors in northern Ontario. A report by the Rural Ontario Municipal Association (ROMA) in January 2024 highlighted the severe impact of Ontario’s healthcare crisis on rural communities, urging provincial action. Presented at the 2024 ROMA Conference, the report, “Fill the Gaps Closer to Home,” offered 22 recommendations to enhance primary and mental health care services in these areas. According to Global News, the Ontario Ministry of Health claimed there is no significant issue with the recruitment and retention of doctors, despite the OMA’s warnings of a severe family doctor shortage affecting over two million residents. This stance comes amid contentious arbitration over physician compensation, with the OMA seeking substantial increases to address inflation and low previous raises. Dr. David Barber of the OMA criticized the provincial government’s position as dangerously dismissive, arguing it downplays the critical need for more family doctors in the province. While addressing these challenges, the federal government is also working to expand its dental care plan to include children under 18 and people with disabilities. However, tensions are mounting between the oral health community and the government. With over one million Canadians soon eligible and over 19,500 providers yet to sign on, only about 10,500 providers have committed since May 2024, despite federal Health Minister Mark Holland’s efforts to address concerns over administrative burdens and patient privacy. The Canadian Dental Association (CDA) and the Ontario Dental Association have previously told the Star they’re in contact with Holland’s office and have had promising discussions, but that some of their concerns are unanswered or have yet to be enshrined in the plan’s terms and conditions. Additionally, in an effort to bolster national research and development, the federal government has also allocated $858.7 million through the Strategic Science Fund(SSF) to 24 research institutions, including the Canadian Institute for Advanced Research (CIFAR) and the Centre for Aging + Brain Health Innovation (CABHI). For the latest industry news and insights, book a free consultation with Delphic Research today!